Journal of Surgical Research
Volume 145, Issue 2 , Pages 214-222 , April 2008

Silymarin, the Antioxidant Component of Silybum marianum, Prevents Sepsis-Induced Acute Lung and Brain Injury

  • Hale Z. Toklu, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
    • ,
  • Tugba Tunali Akbay, Ph.D.

      Affiliations

    • Department of Biochemistry, School of Dentistry, Istanbul, Turkey
    • ,
  • Ayliz Velioglu-Ogunc, Ph.D.

      Affiliations

    • Vocational School of Health Related Professions, Istanbul, Turkey
    • ,
  • Feriha Ercan, Ph.D.

      Affiliations

    • Department of Histology-Embryology, School of Medicine, Istanbul, Turkey
    • ,
  • Nursal Gedik, M.D.

      Affiliations

    • Department of Kasimpasa Military Hospital, Division of Biochemistry, Istanbul, Turkey
    • ,
  • Meral Keyer-Uysal, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
    • ,
  • Goksel Sener, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Marmara University, School of Pharmacy, Tıbbiye Cad. 34668 İstanbul, Turkey.

Received 12 December 2006

References 

  1. Neviere RR, Ceepinskas G, Madorin WS, et al. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes. Am J Physiol 999;277:H885.
  2. Bian K, Murad F. Diversity of endotoxin-induced nitrothyrosine formation in macrophage-endothelium-rich organs. Free Rad Biol Med. 2001;31:421
  3. Heller AR, Groth G, Heller SC, et al. Acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med. 2001;29:272
  4. Milk Thistle (Silybum marianum) in PDR for Herbal Medicines. In: Montvale, NJ: Medical Economics Company; 2000;p. 516–520
  5. Rainone F. Milk thistle. Am Family Physician. 2005;72:1285
  6. Sonnenbichler J, Scalera F, Sonnenbichler I, et al. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther. 1999;290:1375
  7. Gazak R, Svobodova A, Psotova J, et al. Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem. 2004;12:5677
  8. Zhao J, Lahiri-Chatterjee M, Sharma Y, et al. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis. 2000;21:811
  9. Katiyar SK. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects. (review) Int J Oncol. 2005;26:169
  10. Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc. 2002;4:21
  11. Sener G, Toklu H, Ercan F, et al. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol. 2005;5:1387
  12. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302
  13. Beutler E. Glutathione in red blood cell metabolism (A Manual of Biochemical Methods). In: New York: Grune & Stratton; 1975;p. 112–114
  14. Hillegass LM, Griswold DE, Brickson B, et al. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods. 1990;24:285
  15. Haklar G, Ozveri ES, Yuksel M, et al. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett. 2001;165:219
  16. Ingram GI, Hills M. Reference method for the one-stage prothrombin time test on human blood (International committee for standardization in hematology). Thromb Haemos. 1976;36:237
  17. Katiyar SK, Korman NJ, Mukhtar H, et al. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst. 1997;89:556
  18. Matsuda T, Ferreri K, Todorov I, et al. Silymarin protects Pancreatic β-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology. 2005;146:175
  19. Minonzio F, Venegoni E, Ongari AM, et al. Modulation of human polymorphonuclear leukocyte function by the flavonoid silybin. Int J Tissue React. 1988;10:223
  20. Sener G, Sehirli O, Cetinel S, et al. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids. 2005;73:453
  21. Muriel P, Mourelle M. The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin. J Appl Toxicol. 1990;10:281
  22. Muriel P, Mourelle M. Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol. 1990;10:275
  23. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489
  24. Bosisio E, Benelli C, Pirola O. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol Res. 1992;25:147
  25. Soto C, Recoba R, Barron H, et al. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136:205
  26. Manna SK, Mukhopadhyay A, Van NT, et al. Silymarin suppresses TNF-induced activation of NF-KB, c-Jun N-terminal kinase, and apoptosis. J Immunol. 1999;163:6800
  27. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol. 2000;7:53
  28. Leng-Peschlow E. Properties and medical use of flavonolignans (silymarin) from Silybum marianum. Phytother Res. 1996;10(suppl):S25
  29. Kang JS, Jeon YJ, Park SK, et al. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol. 2004;67:175
  30. Ito T, Kawahara K, Nakamura T, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 2007;5:109
  31. Ware LB, Camerer E, Welty-Wolf K, et al. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;291:L307
  32. Bachlie E. History of thromboplastin. Br J Haematol. 2000;110:248
  33. Ashkinazi IIa. Functional deficiency of erythrocyte tissue factor. Bull Exp Biol Med. 1977;83:664
  34. Lwaleed BA. Tissue factor: biological function and clinical significance. Saudi Med J. 2002;23:135
  35. Utter GH, Owings JT, Jacoby RC, et al. Injury induced increased monocyte expression of tissue factors: factor associated with head injury attenuate the injury related monocyte expression of tissue factor. J Trauma. 2002;52:1071
  36. Lupu C, Westmuckett AD, Peer G, et al. Tissue factor dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am J Pathol. 2005;167:1161
  37. Balk RA. Severe sepsis and septic shock (Definitions, epidemiology, and clinical manifestations). Crit Care Clin. 2000;16:179

PII: S0022-4804(07)00237-5

doi: 10.1016/j.jss.2007.03.072

Journal of Surgical Research
Volume 145, Issue 2 , Pages 214-222 , April 2008

Article Tools

* Image Usage & Resolution